Leiden, The Netherlands – September 15, 2025 – ProteoNic, a leader in premium vector technology for biologics and cell and gene therapy, today announced the launch of its novel 2G UNic® transposon ...

SAN DIEGO, July 9, 2025 /PRNewswire/ -- Transposon Therapeutics, a biotechnology company focused on developing novel, orally administered therapies for the treatment of neurodegenerative and ...

Treatment with TPN-101 showed clinical benefits on key clinical outcome measures, including the Revised ALS Functional Rating Scale (ALSFRS-R) and Slow Vital Capacity (SVC) SAN DIEGO, Nov. 6, 2024 ...

The lack of some genes in the BEC/TCEAL cluster could be related to some alterations associated with the autism spectrum disorder, according to a preclinical study published in the journal Genome ...

Transposon mutagenesis has emerged as a robust genome-wide approach for the identification of cancer driver genes. By harnessing the natural mobility of transposable elements, researchers can induce ...

NEWARK, Calif.--(BUSINESS WIRE)--ATUM (formerly DNA2.0 Inc.), a pioneer in bioengineering solutions, announce the issuance of patent No. 10,041,077 by the U.S. Patent and Trademark Office (USPTO) for ...

Triple-negative breast cancer (TNBC) has the worst prognosis of any breast cancer subtype. To better understand the genetic forces driving TNBC, we performed a transposon mutagenesis screen in a ...

Substantial new evidence that health becomes endangered when aging cells lose control of rogue elements of DNA called transposons has been provided by recent research. A new study increases and ...

SAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) -- Transposon Therapeutics, a biotechnology company developing therapies for the treatment of neurodegenerative and aging-related diseases, today announced ...

To exit the nucleus, ordinary RNA cargo must submit to rigorous quality control procedures. Transposon-silencing RNA, however, avoids all that. In fact, transposon-silencing RNA—PIWI-interacting RNA ...